Fig. 3From: Silencing of microRNA-210 inhibits the progression of liver cancer and hepatitis B virus-associated liver cancer via targeting EGR3Silencing of miRNA-210 inhibited the viability of HepG2 a and HepG2.2.15 b cells. * P < 0.05 compared with the Blank group. The experiment was performed in triplicate, and data were expressed as mean ± standard deviation (SD)Back to article page